Vivo Biosciences, Inc.

Biomedical R&D

UEI
SK1FNMRA3497
CAGE
45BN3
Primary NAICS
621991 Blood and Organ Banks
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
vivobiotech.com
Founded
2004
Employees
1K-5K
Estimated annual revenue
$250M-$500M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Vivo Biosciences, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
"sbir phase i new 3D hubiogel culture system for cancer stem cells expansion & analysis" Contract · HHSN261201500066C National Cancer Institute $219,812
Vivo biosciences INC:1105872 [15-068317] Contract · HHSN261201500068C National Cancer Institute $1,882,456
New high throughput anti-tumor drug screening system Grant · R43CA183229 National Institutes of Health $156,981
New functionally-graded biohybrid vascular graft Grant · R41TR001009 National Institutes of Health $217,314
Support- administrative: other Contract · HHSN261201300026C National Cancer Institute $279,406

Quick answers

What is Vivo Biosciences, Inc.'s UEI?

Vivo Biosciences, Inc.'s Unique Entity ID (UEI) in SAM.gov is SK1FNMRA3497.

What is Vivo Biosciences, Inc.'s CAGE code?

Vivo Biosciences, Inc.'s CAGE code is 45BN3.

What is Vivo Biosciences, Inc.'s primary NAICS code?

Vivo Biosciences, Inc.'s primary NAICS code is 621991 (Blood and Organ Banks).

Is Vivo Biosciences, Inc. registered in SAM.gov?

Vivo Biosciences, Inc.'s SAM.gov registration expired on November 28, 2018.

What is Vivo Biosciences, Inc.'s most recent federal award?

Vivo Biosciences, Inc.'s most recent federal contract award is "sbir phase i new 3D hubiogel culture system for cancer stem cells expansion & analysis" (HHSN261201500066C), from National Cancer Institute, on September 22, 2015.

On GovTribe

See Vivo Biosciences, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors